Jeff Yass’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBRX
BSWM
Jeff Yass's MBRX Position: Q3 2026 in Review
Jeff Yass opened a new position in Moleculin Biotech (MBRX) in Q3 2026: 729 shares worth $7.3K. The stake represents ﹤0.01% of the portfolio and ranks #13257 among its holdings. This is a return to the name: Jeff Yass previously reported a position in MBRX as recently as Q1 2023.
Jeff Yass first reported a position in MBRX in Q2 2017 and has held it in 4 quarters since. The position peaked at $137K in Q4 2019. 19 funds tracked by Wall St. Rank hold MBRX as of Q3 2026.
- Jeff Yass held 729 shares of Moleculin Biotech worth $7.3K as of Q3 2026.
- Moleculin Biotech was a new Jeff Yass position in Q3 2026.
- Moleculin Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13257 holding.
- Jeff Yass first reported a position in Moleculin Biotech in Q2 2017 and has held it in 4 quarters since.
- Jeff Yass's Moleculin Biotech position peaked at $137K in Q4 2019.
- 19 funds tracked by Wall St. Rank held Moleculin Biotech as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.